Hypertension, nitric oxide, oxidants, and dietary plant polyphenols

Current Pharmaceutical Biotechnology

Volumn 11, Issue 8, 2010, Pages 837-848

  Galleano, Monica ^a   Pechanova, Olga ^b   Fraga, Cesar G ^a,c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidants; Hypertension; Nitric oxide; NOS; NOX; Polyphenols; Renin angiotensin

Indexed keywords

CATECHIN; EPICATECHIN; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; FLAVONOL DERIVATIVE; ISOFLAVONE DERIVATIVE; NITRIC OXIDE; OXIDIZING AGENT; PHYTOESTROGEN; POLYPHENOL; PROCYANIDIN DERIVATIVE; QUERCETIN; REACTIVE OXYGEN METABOLITE; STILBENE DERIVATIVE; ANTIOXIDANT; FLAVONOID; PHENOL DERIVATIVE; PLANT MEDICINAL PRODUCT; POLYPHENOLS;

BLOOD PRESSURE REGULATION; CACAO; DRUG METABOLISM; DRUG STRUCTURE; GRAPE; HYPERTENSION; NONHUMAN; REVIEW; TEA; WINE; ANIMAL; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHEMISTRY; DIET THERAPY; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; PHYSIOLOGY; PHYTOTHERAPY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALIA; THEOBROMA CACAO; VITACEAE;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; FLAVONOIDS; HUMANS; HYPERTENSION; MALE; NITRIC OXIDE; OXIDANTS; PHENOLS; PHYTOTHERAPY; PLANT PREPARATIONS; RATS; RATS, INBRED SHR; REACTIVE OXYGEN SPECIES;

EID: 78650735365     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110793262114     Document Type: Review

References (135)

1. Franco, V.; Oparil, S.; Carretero, O.A. Hypertensive therapy: Part I. Circulation. 2004, 109. 2953-2958.
2. Appel, L.J.; Champagne, C.M.; Harsha, D.W.; Cooper, L.S.; Obarzanek, E.; Elmer, P.J.; Stevens, V.J.; Vollmer, W.M.; Lin, PH.; Svetkey, L.P.; Stedman, S.W.; Young, D.R. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. J. Am. Med. Assoc. 2003, 289. 2083-2093.
3. Abelson, P.H.; Hines, P.J. The plant revolution. Science. 1999, 285. 367-368.
4. Crozier, A.; Jaganath, I.B.; Clifford M.N. Dietary phenolics: chemistry, bioavailability and effects on health. Nat. Prod. Rep. 2009, 26. 1001-1043.
5. Marks, S.C.; Mullen, W.; Crozier, A. Flavonoid and chlorogenic acid profiles of English cider apples. J. Sci. Food Agric. 2007, 87. 719-728.
6. Crozier, A.; Yokota, T.; Jaganath, I.B.; Marks, S.C.; Saltmarsh, M.; Clifford, M.N. In: Plant Secondary Metabolites and the Human Diet. Crozier, A., Ashihara, H., Clifford, M.N., Eds.; Blackwell Publishing: Oxford, 2006; pp. 208-302.
7. Makris, D.P.; Rossiter, J.T. Domestic processing of onion bulbs (Allium cepa) and asparagus spears (Asparagus officinalis): Effect on flavonol content and antioxidant status. J. Agric. Food Chem., 2001, 49. 3216-3222.
8. Peterson, J.; Dwyer, M.S.J. Flavonoids: Dietary occurrences and biochemical activity. Nutr. Res. 1998, 18. 1995-2018.
9. Jaganath, I.B.; Crozier, A. In: Plant Phenolics and Human Health: Biochemistry, Nutrition, and Pharmacology. Fraga C.G., Ed.; John Wiley & Sons: Hoboken, New Jersey, 2010; pp. 1-49.
10. Del Rio, D.; Stewart, A.J.; Mullen, W.; Burns, J.; Lean, M.E.J.; Brighenti, F.; Crozier, A. HPLC-MSn analysis of phenolic compounds and purine alkaloids in green and black tea. J. Agric. Food Chem., 2004, 52. 2807-2815.
11. Franke, A.A.; Ashburn, L.A.; Kakazu, K.; Suzuki, S.; Wilkens, L.R., Halm, B.M. Apparent bioavailability of isoflavones after intake of liquid and solid soya foods. Br. J. Nutr., 2009, 102. 1203-1210.
12. Kao, T-H.; Chen, B-H. Functional components in soybean cake and their effects on antioxidant activity. J. Agric. Food Chem. 2006, 54, 7544-7555
13. Dixon, R.A.; Ferreira, D. Genistein. Phytochemistry. 2002, 60. 205-211.
14. Burns, J.; Yokota, T.; Ashihara, H.; Lean, M.E. J; Crozier, A. Plant foods and herbal sources of resveratrol. J. Agric. Food Chem. 2002, 50. 3337-3340.
15. Rimando, A.M.; Kalt, W.; Magee, J.B.; Dewey, J.; Ballington J.R. Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J. Agric. Food Chem. 2004, 52. 4713-4719.
16. Soleas, G.J.; Diamandis, E.P.; Goldberg, D.M. Wine as a biological fluid: history, production, and role in disease prevention. J. Clin. Lab. Anal. 1997, 11. 287-313.
17. Piech, A.; Dessy, C.; Havaux, X.; Feron, O.; Balligan, J-C. Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovasc. Res. 2003, 57. 456-467.
18. Ghafourifar, P.; Richter, C. Nitric oxide synthase activity in mitochondria. FEBS Lett., 1997, 418. 291-296.
19. Giulivi, C.; Poderoso, J.J.; Boveris, A. Production of nitric oxide by mitochondria. J. Biol. Chem. 1998, 273. 11038-11043.
20. Ignarro, L.J.; Byrns, R.E.; Sumi, D.; de Nigris, F.; Napoli, C. Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide. Nitric Oxide. 2006, 15. 93-102.
21. Paravicini, T.M.; Touyz, R.M. Redox signaling in hypertension. Cardiovasc. Res. 2006, 71, 247-258.
22. Boveris, A.; Cadenas, E. Mitochondrial production of superoxide anions and its relationship to the antimycin insensitive respiration. FEBS Lett., 1975, 54. 311-314.
23. Turrens, J.F.; Boveris, A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 1980, 191. 421-427.
24. Sarkis, A.; Roman, R.J. Role of cytochrome P450 metabolites of arachidonic acid in hypertension. Curr. Drug Metab., 2004, 5. 245-256.
25. Ward, R.; Cirkovic-Vellichovia, T.; Ledeque, F.; Tirizitis, G.; Dubars, G.; Datla, K.; Dexter, D.; Heushling, P.; Crichton, R. Neuroprotection by taurine and taurine analogues. Adv. Exp. Med. Biol., 2006, 583, 299-306.
26. Touyz, R.M. Recent advances in intracellular signalling in hypertension. Curr. Opin. Nephrol. Hypertens. 2003, 12. 165-174.
27. Brewster, U.C.; Setaro, J.F.; Perazella, M.A. The reninangiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am. J. Med. Sci., 2003, 326. 15-24.
28. Zhang, H.; Schmeisser, A.; Garlichs, C.D.; Plötze, K.; Damme, U.; Mügge; Werner, G.D. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membranebound NADH-/NADPH-oxidases. Cardiovasc. Res. 1999, 44. 215-222.
29. Griendling, K.K.; Sorescu, D.; Lassègue, B.; Ushio-Fukai, M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol., 2000, 20. 2175-2183.
30. Seshiah, P.N.; Weber, D.S.; Rocic, P.; Valppu, L.; Taniyama, Y.; Griendling, K.K. Angiotensin II Stimulation of NAD(P)H Oxidase Activity. Upstream Mediators. Circ. Res., 2002, 91. 406-413.
31. Mollnau, H.; Wendt, M.; Szöcs, M.; Lassègue, B.; Schulz, E.; Oelze, M.; Li, H; Bodenschatz, M.; August, M.; Kleschyov, A.L.; Tsilimingas, N.; Walter, U.; Förstermann, U.; Meinertz, T.; Griendling, K.K.; Münzel, T. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ. Res. 2002, 90. E58-E65.
32. Grossman, E. Does increased oxidative stress cause hypertension? Diab. Care. 2008, 2. S185-S189.
33. Pechanova, O.; Simko, F. Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind. J. Hypertens. 2009, Suppl 6, S32-S36.
34. Duffy, S.J.; Gokce, N.; Holbrook, M.; Huang, A.; Frei, B.; Keaney, J.F. Jr.; Vita, J.A. Treatment of hypertension with ascorbic acid. Lancet, 1999, 354. 2048-2049.
35. Fotherby, M.D.; Williams, J.C.; Forster, L.A.; Craner, P.; Ferns, G.A. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J. Hypertens., 2000, 18. 411-415.
36. Hajjar, I.M.; George, V.; Sasse, E.A.; Kochar, M.S. A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am. J. Ther. 2002, 9. 289-293.
37. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 2002, 360. 23-33.
38. Kim, M.K.; Sasaki, S.; Sasazuki, S.; Okubo, S.; Hayashi, M.; Tsugane, S. Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension, 2002, 40. 797-803.
39. Palumbo, G.; Avanzini, F.; Alli, C.; Roncaglioni, M.C.; Ronchi, E.; Cristofari, M.; Capra, A.; Rossi, S.; Nosotti, L.; Costantini, C.; Cavalera, C. Effects of vitamin E on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)--Hypertension study. Am. J. Hypertens. 2000, 13. 564-567.
40. Rumbold, A.R.; Crowther, C.A.; Haslam, R.R.; Dekker, G.A.; Robinson, J.S.; ACTS Study Group. Vitamins C and E and the risks of preeclampsia and perinatal complications. N. Engl. J. Med. 2006, 354. 1796-1806.
41. Ward, N.C.; Hodgson, J.M.; Croft, K.D.; Burke, V.; Beilin, L.J.; Puddey, I.B. The combination of vitamin C and grape-seed polyphenols increases blood pressure: a randomized, double-blind, placebo-controlled trial. J. Hypertens. 2005, 23. 427-434.
42. Renaud, S.; de Lorgeril, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992, 339. 1523-1526.
43. Opie, L.H.; Lecour, S. The red wine hypothesis: from concepts to protective signalling molecules. Eur. Heart J. 2007, 28. 1683-1693.
44. Buijsse, B.; Freskens, E. J.; Kok, F.J.; Kromhout, D. Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch. Intern. Med. 2006, 166. 411-417.
45. McCullough, M.L.; Chevaux, K.; Jackson, L.; Preston, M.; Martinez, G.; Schmitz, H.H.; Coletti, C.; Campos, H.; Hollenberg, N.K. Hypertension, the Kuna, and the epidemiology of flavanols. J. Cardiovasc. Pharmacol., 2006, 47. S103-S109.
46. Park, Y.K.; Kim, J.S.; Kang, M.H. Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double-blind, placebo controlled intervention trial. Biofactors. 2004, 22. 145-147.
47. Hansen, A.S.; Marckmann, P. Effect of red wine and red grape extract on blood lipids, haemostatic factors, and other risk factors for cardiovascular disease. Eur. J. Clin. Nutr., 2005, 59. 449-455.
48. Taubert, D.; Berkels, R.; Roesen, R.; Klaus, W. Chocolate and blood pressure in elderly individuals with isolated systolic hypertension. J. Am. Med. Assoc., 2003, 290. 1029-1030.
49. Engler, M.B.; Engler, M.M.; Malloy, M.J.; Browne, A.; Chiu, E.Y.; Kwak, H.K.; Milbury, P.; Paul, S.M.; Blumberg, J.; Mietus-Snyder, M.L. Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J. Am. Coll. Nutr., 2004, 23. 197-204.
50. Fraga, C.G.; Actis-Goretta, L.; Ottaviani, J.I.; Carrasquedo, F.; Lotito, S.B.; Lazarus, S.; Schimtz, H.H.; Keen, C.L. Regular consumption of a flavanol-rich chocolate can improve oxidant stress in young soccer players. Clin. Dev. Immunol., 2005, 12. 11-17.
51. Grassi, D.; Lippi, C.; Necozioni, S.; Desideri, G.; Ferri, C. Shortterm administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am. J. Clin. Nutr., 2005, 81. 611-614.
52. Grassi, D.; Necozione, S.; Lippi, C.; Croce, G.; Valeri, L.; Pasqualetti, P.; Desideri, G.; Blumberg, J.B.; Ferri, C. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension, 2005, 46. 398-405.
53. Taubert, D.; Roesen, R.; Lehmann, C.; Jung, N.; Schömig, E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide. A randomized controlled trial. J. Am. Med. Assoc., 2007, 298. 49-60.
54. Muniyappa, R.; Hall, G.; Kolodziej, T.L.; Karne, R.J.; Crandon, S.K.; Quon, M.J. Cocoa consumption for 2 wk enhances insulinmediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. Am. J. Clin. Nutr., 2008, 88. 1685-1696.
55. Crews, W.D. Jr.; Harrison, D.W.; Wright, J.W. A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults. Am. J. Clin. Nutr., 2008, 87. 872-880.
56. Allen, R.R.; Carson, L.; Kwik-Uribe, C.; Evans, E.M.; Erdman, J.W. Jr. Daily consumption of a dark chocolate containing flavanols and added sterol esters affects cardiovascular risk factors in a normotensive population with elevated cholesterol. J. Nutr., 2008, 138. 725-731.
57. Grassi, D.; Desideri, G.; Necozione, S.; Lippi, C.; Casale, R.; Properzi, G.; Blumberg, J.B.; Ferri, C. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J. Nutr., 2008, 138. 1671-1676.
58. Faridi, Z.; Njike, V.Y.; Dutta, S.; Ali, A.; Katz, D.L. Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am. J. Clin. Nutr., 2008, 88. 58-63.
59. Balzer, J.; Rassaf, T.; Heiss, C.; Kleinbongard, P.; Lauer, T.; Merx, M.; Heussen, N.; Gross, H.B.; Keen, C.L.; Schroeter, H.; Kelm, M. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J. Am. Coll. Cardiol., 2008, 51. 2141-2149.
60. Njike, V.Y.; Faridi, Z.; Shuval, K.; Dutta, S.; Kay, C.D.; West, S.G.; Kris-Etherton, P.M.; Katz, D.L. Effects of sugar-sweetened and sugar-free cocoa on endothelial function in overweight adults. Int. J. Cardiol., 2009 Dec 23. [Epub ahead of print].
61. Ried, K.; Frank, O.R.; Stocks, N.P. Dark chocolate or tomato extract for prehypertension: a randomised controlled trial. BMC Compl. Altern. Med., 2009, 9, 22.
62. Berry, N.M.; Davison, K.; Coates, A.M.; Buckley, J.D.; Howe, P.R. Impact of cocoa flavanol consumption on blood pressure responsiveness to exercise. Br. J. Nutr., 2010, 103. 1480-1484.
63. Davison, K.; Berry, N.M.; Misan, G.; Coates, A.M.; Buckley, J.D.; Howe, P.R. Dose-related effects of flavanol-rich cocoa on blood pressure. J. Hum. Hypertens., 2010 Jan 21. [Epub ahead of print]
64. Bingham, S.A.; Vorster, H.; Jerling, J.C.; Magee, E.; Mulligan, A.; Runswick, S.A.; Cummings, J.H. Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br. J. Nutr., 1997, 78. 41-55.
65. Hodgson, J.M.; Puddey, I.B.; Burke, V.; Beilin, L.J.; Jordan, N. Effects on blood pressure of drinking green and black tea. J. Hypertens., 1999, 17. 457-463.
66. Duffy, S.J.; Keaney, J.F. Jr.; Holbrook, M.; Gokce, N.; Swerdloff, P.L.; Frei, B.; Vita, J.A. Short-and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation, 2001, 104. 151-156.
67. Nagao, T.; Hase, T.; Tokimitsu, I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring), 2007, 15. 1473-1483.
68. Mukamal, K.J.; MacDermott, K.; Vinson, J.A.; Oyama, N.; Manning, W.J.; Mittleman, M.A. A 6-month randomized pilot study of black tea and cardiovascular risk factors. Am. Heart J. 2007, 154. 724 e1-6.
69. Matsuyama, T.; Tanaka, Y.; Kamimaki, I.; Nagao, T.; Tokimitsu, I. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity (Silver Spring), 2008, 16. 1338-1348.
70. Frank, J.; George, T.W.; Lodge, J.K.; Rodriguez-Mateos, A.M.; Spencer, J.P., Minihane, A.M.; Rimbach, G. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J. Nutr., 2009, 139. 58-62.
71. Grassi, D.; Desideri, G.; Croce, G.; Tiberti, S.; Aggio, A.; Ferri, C. Flavonoids, vascular function and cardiovascular protection. Curr. Pharm. Des., 2009, 15. 1072-1084.
72. Conquer, J.A.; Maiani, G.; Azzini, E.; Raguzzini, A.; Holub, B.J. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J. Nutr., 1998, 128. 593-597.
73. Egert, S.; Bosy-Westphal, A.; Seiberl, J.; Kürbitz, C.; Settler, U.; Plachta-Danielzik, S.; Wagner, A.E.; Frank, J.; Schrezenmeir, J.; Rimbach, G.; Wolffram, S.; Müller, M.J. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a highcardiovascular disease risk phenotype: a double-blinded, placebocontrolled cross-over study. Br. J. Nutr., 2009, 102, 1065-1074.
74. Edwards, R.L.; Lyon, T.; Litwin, S.E.; Rabovsky, A.; Symons, J.D.; Jalili, T. Quercetin reduces blood pressure in hypertensive subjects. J. Nutr., 2007, 137. 2405-2411.
75. Egert, S.; Boesch-Saadatmandi, C.; Wolffram, S.; Rimbach, G.; Müller, M.J. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J. Nutr., 2010, 140. 278-284.
76. Brown, A.L.; Lane, J.; Coverly, J.; Stocks, J.; Jackson, S.; Stephen, A.; Bluck, L.; Coward, A.; Hendrickx, H. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br. J. Nutr., 2009, 101. 886-894.
77. Washburn, S.; Burke, G.L.; Morgan, T.; Anthony, M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause, 1999, 6. 7-13.
78. Teede, H.J.; Dalais, F.S.; Kotsopoulos, D.; Liang, Y.L.; Davis, S.; McGrath, B.P. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J. Clin. Endocrinol. Metab., 2001, 86. 3053-3060.
79. Rivas, M.; Garay, R.P.; Escanero, J.F.; Cia, P. Jr.; Cia, P.; Alda, J.O. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J. Nutr., 2002, 132. 1900-1902.
80. Jenkins, D.J.; Kendall, C.W.; Jackson, C.J.; Connelly, P.W.; Parker, T.; Faulkner, D.; Vidgen, E.; Cunnane, S.C.; Leiter, L.A.; Josse, R.G. Effects of high-and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am. J. Clin. Nutr., 2002, 76. 365-372.
81. Atkinson, C.; Oosthuizen, W.; Scollen, S.; Loktionov, A.; Day, N.E.; Bingham, S.A. Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old women. J. Nutr., 2004, 134. 1759-1764.
82. Kreijkamp-Kaspers, S.; Kok, L.; Bots, M.L.; Grobbee, D.E.; Lampe, J.W.; van der Schouw, Y.T. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am. J. Clin. Nutr., 2005, 81. 189-195.
83. Teede, H.J.; Giannopoulos, D.; Dalais, F.S.; Hodgson, J.; McGrath, B.P. Randomised, controlled, cross-over trial of soy protein with isoflavones on blood pressure and arterial function in hypertensive subjects. J. Am. Coll. Nutr., 2006, 25. 533-540.
84. Welty, F.K.; Lee, K.S.; Lew, N.S.; Zhou, J.R. Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women. Arch. Intern. Med., 2007, 167. 1060-1067.
85. Stensvold, I.; Tverdal, A.; Solvoll, K.; Foss, O.P. Tea consumption. relationship to cholesterol, blood pressure, and coronary and total mortality. Prev. Med., 1992, 21. 546-553.
86. Yang, Y.C.; Lu, F.H.; Wu, J.S.; Wu, C.H.; Chang, C.J. The protective effect of habitual tea consumption on hypertension. Arch. Intern. Med., 2004, 164. 1534-1540.
87. Chun, O.K.; Chung, S.J.; Song, W.O. Estimated dietary flavonoid intake and major food sources of U.S. adults. J. Nutr., 2007, 137. 1244-1252.
88. Yang, G.; Shu, X.O.; Jin, F.; Zhang, X.; Li, H.L.; Li, Q.; Gao, Y.T.; Zheng, W. Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am. J. Clin. Nutr., 2005, 81. 1012-1017.
89. Nagata, C.; Shimizu, H.; Takami, R.; Hayashi, M.; Takeda, N.; Yasuda, K. Association of blood pressure with intake of soy products and other food groups in Japanese men and women. Prev. Med., 2003, 36. 692-697.
90. Sacks, F.M.; Lichtenstein, A.; Van Horn, L.; Harris, W.; Kris-Eherton, P.; Winston, M.; American Heart Association Nutrition Committee. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation, 2006, 113. 1034-1044.
91. Hooper, L.; Kroon, P.A.; Rimm, E.B.; Cohn, J.S.; Harvey, I.; Le Cornu, K.A.; Ryder, J.J.; Hall, W.L.; Cassidy, A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr., 2008, 88. 38-50.
92. Taubert, D.; Roesen, R.; Schömig, E. Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch. Intern. Med., 2007, 167. 626-634.
93. Schroeter, H.; Heiss, C; Balzer, J.; Kleinbongard, P.; Keen, C.L.; Hollenberg, N.K.; Sies, H.; Kwik-Uribe, C.; Schmitz, H.H.; Kelm, M. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. USA, 2006, 103. 1024-1029.
94. Loke, W.M.; Hodgson, J.M.; Proudfoot, J.M.; McKinley, A.J.; Puddey, I.B.; Croft, K.D. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am. J. Clin. Nutr., 2008, 88. 1018-1025.
95. Pechanova, O.; Bernatova, I.; Babal, P.; Martinez, M.C.; Kysela, S.; Stvrtina, S.; Andriantsitohaina, R. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J. Hypertens., 2004, 22. 1551-1559.
96. Jiménez, R.; López-Sepúlveda, R.; Kadminir, M.; Romero, M.; Vera, R.; Sánchez, M.; Vargas, F.; O'Valle, F.; Zarzuelo, A.; Dueñas, M.; Santos-Buelga, C.; Duarte, J. Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase. Free Radic. Biol. Med., 2007, 43. 462-473.
97. Galati, E.M.; Trovato, A.; Kirjavainen, S.; Forestieri, A.M.; Rossitto, A.; Monforte, M.T. Biological effects of hesperidin, a Citrus flavonoid. (Note III): antihypertensive and diuretic activity in rat. Farmaco, 1996, 51. 219-221.
98. Ohtsuki, K.; Abe, A.; Mitsuzuwi, H.; Kondo, M.; Uemura, K.; Iwasaki, Y.; Kondo, Y. Effects of long-term administration of hesperidin and glucosyl hesperidin to spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. (Tokyo), 2002, 48. 420-422.
99. Villar, I.C.; Jiménez, R.; Galisteo, M.; García-Saura, M.F.; Zarzuelo, A.; Duarte, J. Effects of chronic chrysin treatment in spontaneously hypertensive rats. Planta Med., 2002, 68. 847-850.
100. Cienfuegos-Jovellanos, E.; Quinones, M. del M.; Muguerza, B.; Moulay, L.; Miguel, M.; Aleixandre, A. Antihypertensive effect of a polyphenol-rich cocoa powder industrially processed to preserve the original flavonoids of the cocoa beans. J. Agric. Food Chem., 2009, 57. 6156-6162.
101. Machha, A.; Mustafa, M.R. Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J. Cardiovasc. Pharmacol., 2005, 46. 36-40.
102. Peng, N.; Clark, J.T.; Prasain, J.; Kim, H.; White, C.R.; Wyss, J.M. Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously hypertensive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2005, 289. R771-775.
103. Yamamoto, M.; Suzuki, A.; Jokura, H.; Yamamoto, N.; Hase, T. Glucosyl hesperidin prevents endothelial dysfunction and oxidative stress in spontaneously hypertensive rats. Nutrition, 2008, 24. 470-476.
104. López-Sepúlveda, R.; Jiménez, R.; Romero, M.; Zarzuelo, M.J.; Sánchez, M.; Gómez-Guzmán, M.; Vargas, F.; O'Valle, F.; Zarzuelo, A.; Pérez-Vizcaíno, F.; Duarte, J. Wine polyphenols improve endothelial function in large vessels of female spontaneously hypertensive rats. Hypertension. 2008, 51. 1088-1095.
105. Negishi, H.; Xu, J.W.; Ikeda, K; Njelekela, M.; Nara, Y.; Yamori, Y. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J. Nutr., 2004, 134. 38-42.
106. Potenza, M.A.; Marasciulo, F.L.; Tarquinio, M.; Tiravanti, E.; Colantuono, G.; Federici, A.; Kim, J.A.; Quon, M.J.; Montagnani, M. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am. J. Physiol. Endocrinol. Metab., 2007, 292. E1378-1387.
107. Sarr, M.; Chataigneau, M.; Martins, S.; Schott, C.; El Bedoui, J.; Oak, M.H.; Muller, B.; Chataigneau, T.; Schini-Kerth, V.B. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc. Res., 2006, 71. 794-802.
108. Papparella, I.; Ceolotto, G.; Montemurro, D.; Antonello, M.; Garbisa, S.; Rossi, G.; Semplicini, A. Green tea attenuates angiotensin II-induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/epidermal growth factor receptor/Akt signaling pathway. J. Nutr., 2008, 138. 1596-1601.
109. Al-Awwadi, N.A.; Araiz, C.; Bornet, A.; Delbosc, S.; Cristol, J.P.; Linck, N.; Azay, J.; Teissedre, P.L.; Cros, G. Extracts enriched in different polyphenolic families normalize increased cardiac NADPH oxidase expression while having differential effects on insulin resistance, hypertension, and cardiac hypertrophy in highfructose-fed rats. J. Agric. Food Chem., 2005, 53. 151-157.
110. Rivera, L.; Morón, R; Zarzuelo, A.; Galisteo, M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem. Pharmacol., 2009, 77. 1053-1063.
111. Miatello, R.; Vázquez, M.; Renna, N.; Cruzado, M.; Zumino, A.P.; Risler, N. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. Am. J. Hypertens., 2005, 18. 864-870.
112. Diebolt, M.; Bucher, B.; Andriantsitohaina, R. Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension, 2001, 38. 159-165.
113. Ralay Ranaivo, H.; Diebolt, M.; Andriantsitohaina, R. Wine polyphenols induce hypotension, and decrease cardiac reactivity and infarct size in rats: involvement of nitric oxide. Br. J. Pharmacol., 2004, 142. 671-678.
114. Benito, S.; López, D.; Saiz, M.P.; Buxaderas, S.; Sanchez, J.; Puig-Parellada, P., Mitjavila, M.T. A flavonoid-rich diet increases nitric oxide production in rat aorta. Br. J. Pharmacol., 2002, 135. 910-916.
115. Pérez-Vizcaíno, F.; Duarte, J.; Jiménez, R.; Santos-Buelga, C.; Osuna, A. Antihypertensive effects of the flavonoid quercetin. Pharmacol. Rep., 2009, 61. 67-75.
116. Sánchez, M.; Galisteo, M.; Vera, R.; Villar, I.C.; Zarzuelo, A.; Tamargo, A.; Pérez-Vizcaíno, F.; Duarte, J. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J. Hypertens., 2006, 24. 75-84.
117. Sánchez, M.; Lodi, F.; Vera, R.; Villar, I.C.; Cogolludo, A.; Jiménez, R.; Moreno, L.; Romero, M.; Tamargo, J.; Pérez-Vizcaíno, F.; Duarte, J. Quercetin and isorhamnetin prevent endothelial dysfunction, superoxide production, and overexpression of p47phox induced by angiotensin II in rat aorta. J. Nutr., 2007, 137. 910-915.
118. Duarte, J.; Galisteo, M.; Ocete, M.A.; Pérez-Vizcaíno, F.; Zarzuelo, A.; Tamargo, J. Effects of chronic quercetin treatment on hepatic oxidative status of spontaneously hypertensive rats. Mol. Cell. Biochem., 2001, 221. 155-160.
119. Duarte, J.; Pérez-Palencia, R.; Vargas, F.; Ocete, M.A.; Pérez-Vizcaíno, F.; Zarzuelo, A.; Tamargo, J. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br. J. Pharmacol., 2001, 133. 117-124.
120. Duarte, J.; Jiménez, R.; O'Valle, F.; Galisteo, M.; Péerez-Valencia, R.; Vargas, F.; Pérez-Vizcaíno, F.; Zarzuelo, A.; Tamargo, J. Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J. Hypertens., 2002, 20. 1843-1854.
121. Galisteo, M.; García-Saura, M.F.; Jiménez, R.; Villar, I.C.; Zarzuelo, A.; Vargas, F.; Duarte, J. Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats. Mol. Cell. Biochem., 2004, 259. 91-99.
122. Yamamoto, Y.; Oue, E. Antihypertensive effect of quercetin in rats fed with a high-fat high-sucrose diet. Biosci. Biotechnol. Biochem., 2006, 70. 933-939.
123. Nevala, R.; Vaskonen, T.; Vehniäinen, J.; Korpela, R.; Vapaatalo, H. Soy based diet attenuates the development of hypertension when compared to casein based diet in spontaneously hypertensive rat. Life Sci., 2000, 66. 115-124.
124. Martin, D.S.; Breitkopf, N.P.; Eyster, K.M.; Williams, J.L. Dietary soy exerts an antihypertensive effect in spontaneously hypertensive female rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2001, 281. R553-560.
125. Martin, D.S.; Williams, J.L.; Breitkopf, N.P.; Eyster, K.M. Pressor responsiveness to angiotensin in soy-fed spontaneously hypertensive rats. Can. J. Physiol. Pharmacol., 2002, 80. 1180-1186.
126. Park, E.; Shin, J.I.; Park, O.J.; Kang, M.H. Soy isoflavone supplementation alleviates oxidative stress and improves systolic blood pressure in male spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. (Tokyo), 2005, 51. 254-259.
127. Mahn, K.; Borras, C.; Knock, G.A.; Taylor, P.; Khan, I.Y.; Sugden, D.; Poston, L.; Ward, J.P.; Sharpe, R.M.; Viña, J.; Aaronson, P.I.; Mann, G.E. Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J., 2005, 19. 1755-1757.
128. Siow, R.C.; Li, F.Y.; Rowlands, D.J.; de Winter, P.; Mann, G.E. Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic. Biol. Med., 2007, 42. 909-925.
129. Palatini, P.; Ceolotto, G.; Ragazzo, F.; Dorigatti, F.; Saladini, F.; Papparella, I.; Mos, L.; Zanata, G.; Santonastaso, M. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J. Hypertens., 2009, 27. 1594-1601.
130. Setchell, K.D.; Brown, N.M.; Lydeking-Olsen, E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J. Nutr., 2002, 132. 3577-3584.
131. Steffen, Y.; Jung, T.; Klotz, L-O.; Schewe, T.; Grune, T.; Sies, H. Protein modification elicited by oxidized low-density lipoprotein (LDL) in endothelial cells: protection by (-)-epicatechin. Free Radic. Biol. Med., 2007, 42. 955-970.
132. Steffen, Y.; Schewe, T.; Sies, H. (-)-Epicatechin elevates nitric oxide in endothelial cells via inhibition of NADPH oxidase. Biochem. Biophys. Res. Commun., 2007, 359. 828-833.
133. Steffen, Y.; Gruber, C.; Schewe, T.; Sies, H. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch. Biochem. Biophys., 2008, 469. 209-219.
134. Fraga, C.G. Plant polyphenols: how to translate their in vitro antioxidant actions to in vivo conditions. IUBMB Life, 2007, 59. 308-315.
135. Galleano, M.; Verstraeten, S.V.; Oteiza, P.I.; Fraga, C.G. Antioxidant actions of flavonoids: thermodynamic and kinetic analysis. Arch. Biochem. Biophys., 2010, April 11, [Epub ahead of Print].